Clorox (NYSE:CLX) Price Target Raised to $173.00

Clorox (NYSE:CLX) had its price target lifted by JPMorgan Chase & Co. from $171.00 to $173.00 in a research note released on Tuesday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Other research analysts have also issued research reports about the stock. DA Davidson upped their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Barclays reduced their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Finally, Evercore ISI lowered their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Stock Up 1.1 %

Shares of CLX stock opened at $147.55 on Tuesday. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The stock has a market cap of $18.26 billion, a PE ratio of 51.41, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The business’s fifty day moving average is $161.83 and its 200-day moving average is $158.67. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same period in the previous year, the business posted $2.16 EPS. Equities analysts expect that Clorox will post 6.86 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.31%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 133.33%.

Hedge Funds Weigh In On Clorox

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. State Street Corp lifted its holdings in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after acquiring an additional 245,525 shares during the period. Mizuho Securities USA LLC lifted its holdings in shares of Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares during the period. Stifel Financial Corp lifted its holdings in Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after purchasing an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp lifted its holdings in Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after purchasing an additional 31,510 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.